ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2171

Functional Measures and Patient Home Self-Assessments in the Idiopathic Inflammatory Myopathies

Amanda Kocoloski1, Courtney Ward2, Diane Koontz2, Chester V. Oddis3 and Rohit Aggarwal4, 1Internal Medicine, Division of Rheumatology, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Internal Medicine Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, 3Rheumatology/Clinical Immunology, Unviersity of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, PA, 4Medicine / Rheumatology, University of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, PA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: functional status, myositis and patient outcomes

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Myositis leads to significant morbidity and loss of function. Currently, simple objective measures of patient functional outcomes are lacking.  Our aims were to a) test functional measures (sit to stand [STS], timed up and go [TUG], and 6-minute walk distance [6MWD]) in myositis patients against established myositis core set measures, and b) evaluate reliability of the same measures self-performed by patients at home.

Methods: We collected data on the 6 validated myositis core measures (manual muscle testing [MMT], physician global disease activity, patient global disease activity, extra-muscular global disease activity, HAQ and muscle enzymes) as well as performed 3 functional measures in clinic (STS, TUG, and 6MWD) on patients with DM, PM and necrotizing myopathy at baseline, 3 and 6 months. STS is number of times a patient can stand from a seated position and sit back down, as many times in 30 seconds. TUG is the time needed to rise from a chair, walk 3 meters, return to the chair and sit down. 6MWD is the maximum distance patient can walk in 6 minutes. We instructed patients on conducting these functional measures at home, and they reported performance results at home within a week of clinic evaluation. To assess validity we compared functional measures against all core set measures at baseline and MMT longitudinally. We examined test-retest reliability of home assessments with in clinic assessments. We use Spearman correlations with rho >0.5 considered strong, 0.35-0.5 moderate, and 0.2-0.35 weak.

Results: Data from 31 patients [58% females, 90% Caucasians, mean age 48 (±16)] from an ongoing observational study were included in this analysis. As shown in table 1, at baseline, STS correlated strongly with  MMT, patient/physician global assessment, and muscle enzymes, and had moderate correlation with HAQ, and no correlation with extra-muscular global.  Similarly, at baseline, TUG showed moderate correlation with physician/patient global and muscle enzymes, but only weak association with MMT, HAQ and extra-muscular global. The 6MWD showed strong correlation with MMT, moderate with patient global and HAQ, and weak with physician global and muscle enzymes. Longitudinally, 6MWD showed strong association with MMT, where as STS and TUG showed moderate and weak associations with MMT respectively. Home assessments of STS (rho: 0.91), TUG (rho: 0.94) and 6MWD (rho: 0.86) showed high test-retest reliability compared to clinic assessment (P<0.01 for all 3).

Conclusion: Preliminary data suggests strong cross sectional correlation of STS and 6MWD with MMT and moderate to strong correlation with MMT longitudinally. All tests were reliable when self-performed by patients at home. This suggests these simple measures may provide objective functional assessment of patient-centric outcomes in myositis in clinic as well as  at home.

  Table 1. Baseline and Longitudinal Comparisons of Core and Functional Measures in Myositis

 

Sit to Stand

Timed Up and Go

6-Minute Walk Distance

Baseline

 

 

 

Manual Muscle Testing

Rho:  0.63; p=<0.01

Rho:  -0.30; p=0.11

Rho: 0.58; p=<0.01

Physician Global

 Rho: -0.56; p=<0.01

Rho:  0.46; p=0.01

Rho: -0.29; p=0.13

Patient Global

Rho: -0.52; p=<0.01

 Rho: 0.48; p=0.01

Rho: -0.37; p=0.05

Extra-Muscular Global

Rho: -0.02; p=0.93

Rho:  0.22; p=0.25

Rho: 0.01; p=0.96

Health Assessment Questionnaire

 Rho: -0.40; p=0.03

Rho:  0.20; p=0.32

Rho: -0.48; p=0.01

Muscle Enzymes

Rho: -0.52; p=0.01

Rho: 0.39; p=0.06

Rho: -0.28; p=0.24

Longitudinal

 

 

 

Manual Muscle Testing

Rho: 0.36; p=0.08

Rho: -0.31; p=0.19

Rho: 0.61; p=<0.01

 


Disclosure: A. Kocoloski, None; C. Ward, None; D. Koontz, None; C. V. Oddis, None; R. Aggarwal, Pfizer Inc, 2,Bristol-Myers Squibb, 2,Mallinckrodt, 2,Genentech and Biogen IDEC Inc., 2,Momenta, 2,Bristol-Myers Squibb, 5,Octapharma, 5,Mallinckrodt, 5.

To cite this abstract in AMA style:

Kocoloski A, Ward C, Koontz D, Oddis CV, Aggarwal R. Functional Measures and Patient Home Self-Assessments in the Idiopathic Inflammatory Myopathies [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/functional-measures-and-patient-home-self-assessments-in-the-idiopathic-inflammatory-myopathies/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-measures-and-patient-home-self-assessments-in-the-idiopathic-inflammatory-myopathies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology